Yüklüyor......
Feasibility of Reducing the Duration of Placebo-Controlled Trials in Schizophrenia Research
Use of placebo-controlled trials in medical and psychiatric research has been controversial, although a consensus is emerging about conditions under which placebo-controlled trials are ethical. In schizophrenia research, the paradigm of slow onset of antipsychotic effects has led to a model in which...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2632413/ https://ncbi.nlm.nih.gov/pubmed/18184634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbm152 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|